BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 2449279)

  • 1. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
    Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
    Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T; Mochizuki M; Nishimura R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of immunoreactive beta-core fragment of hCG.
    de Medeiros SF; Amato F; Norman RJ
    Obstet Gynecol; 1991 Jan; 77(1):53-9. PubMed ID: 1984227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
    Marcillac I; Troalen F; Bidart JM; Ghillani P; Ribrag V; Escudier B; Malassagne B; Droz JP; Lhommé C; Rougier P
    Cancer Res; 1992 Jul; 52(14):3901-7. PubMed ID: 1377600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Following metastatic placental site trophoblastic tumor with urine beta-core fragment.
    Rinne K; Shahabi S; Cole L
    Gynecol Oncol; 1999 Aug; 74(2):302-3. PubMed ID: 10419751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity and detection limit of ten pregnancy tests.
    Alfthan H; Björses UM; Tiitinen A; Stenman UH
    Scand J Clin Lab Invest Suppl; 1993; 216():105-13. PubMed ID: 7690982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fragments of human chorionic gonadotropin (hCG): diagnosis of pregnancy and tumors].
    Lechner O; Dirnhofer S; Gerth R; Merz WE; Wick G; Berger P
    Wien Klin Wochenschr; 1995; 107(1):15-9. PubMed ID: 7871785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beta-core fragment of human chorionic gonadotropin: biochemical background and clinical application.
    Schutter EM; Mulder C; van Kamp GJ; Kenemans P
    Anticancer Res; 1997; 17(2B):1255-72. PubMed ID: 9137483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG beta fragment from standard reference preparations and raw urine samples.
    Birken S; Chen Y; Gawinowicz MA; Lustbader JW; Pollak S; Agosto G; Buck R; O'Connor J
    Endocrinology; 1993 Sep; 133(3):1390-7. PubMed ID: 7689955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UGP in urogenital disorders: Egyptian experience.
    el-Ahmady O; Halim AB; Gad M; Walker R
    Anticancer Res; 1996; 16(4B):2301-8. PubMed ID: 8694560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors.
    Hoermann R; Gerbes AL; Spoettl G; Jüngst D; Mann K
    Cancer Res; 1992 Mar; 52(6):1520-4. PubMed ID: 1540961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of antibodies to the urinary fragment of the human chorionic gonadotropin beta-subunit.
    Krichevsky A; Armstrong EG; Schlatterer J; Birken S; O'Connor J; Bikel K; Silverberg S; Lustbader JW; Canfield RE
    Endocrinology; 1988 Jul; 123(1):584-93. PubMed ID: 2454812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactivity of a commercial chemiluminescence immunoassay for human chorionic gonadotropin with the free beta-subunit.
    Luppa P; Spöttl G; Saller B; Neumeier D; Mann K
    J Biolumin Chemilumin; 1992 Jul; 7(3):195-201. PubMed ID: 1381136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix.
    Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
    Gynecol Oncol; 1994 Nov; 55(2):271-6. PubMed ID: 7525427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of HCG and hCG beta determinations.
    Mann K; Saller B; Hoermann R
    Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.